Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK PathwayXinhui Wu, Haixiao Chen|Drug Design Development and Therapy|2021Cited by 23